3-iodobenzylguanidine has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caballero, C; Cordero, J; Crespo, A; Díez, L; Rioja, M | 1 |
| Abe, I; Fujishima, M; Fujishima, S; Kagiyama, S; Kaseda, S; Kuwabara, Y; Ohmori, S; Ohya, Y; Onaka, U; Sasaki, M | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Goldblatt Syndrome
| Article | Year |
|---|---|
Myocardial imaging with 123I-metaiodobenzylguanidine in essential hypertension and renovascular hypertension.
Topics: 3-Iodobenzylguanidine; Adult; Echocardiography; Female; Heart; Humans; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2001 |
1 other study(ies) available for 3-iodobenzylguanidine and Goldblatt Syndrome
| Article | Year |
|---|---|
[Congenital cyanotic heart disease and peripheral neurogenic tumor].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Chronic Disease; Dextrocardia; Epilepsy, Tonic-Clonic; Fatal Outcome; Heart Defects, Congenital; Humans; Hypertension; Hypertension, Renovascular; Hypoxia; Male; Metanephrine; Paraganglioma; Pentetic Acid; Pulmonary Edema; Renal Artery; Situs Inversus; Tomography, Emission-Computed, Single-Photon | 1999 |